AU7660900A - Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid - Google Patents

Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid

Info

Publication number
AU7660900A
AU7660900A AU76609/00A AU7660900A AU7660900A AU 7660900 A AU7660900 A AU 7660900A AU 76609/00 A AU76609/00 A AU 76609/00A AU 7660900 A AU7660900 A AU 7660900A AU 7660900 A AU7660900 A AU 7660900A
Authority
AU
Australia
Prior art keywords
acid
therapeutic system
transdermal therapeutic
salicylic acid
administering acetylsalicylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76609/00A
Inventor
Hanshermann Franke
Gerd Hoffmann
Heinrich Kindel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU7660900A publication Critical patent/AU7660900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AU76609/00A 1999-10-13 2000-09-30 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid Abandoned AU7660900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19949202A DE19949202A1 (en) 1999-10-13 1999-10-13 Transdermal therapeutic system for the delivery of acetylsalicylic acid and / or salicylic acid
DE19949202 1999-10-13
PCT/EP2000/009617 WO2001026637A2 (en) 1999-10-13 2000-09-30 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid

Publications (1)

Publication Number Publication Date
AU7660900A true AU7660900A (en) 2001-04-23

Family

ID=7925396

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76609/00A Abandoned AU7660900A (en) 1999-10-13 2000-09-30 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid

Country Status (8)

Country Link
EP (1) EP1220661B1 (en)
JP (1) JP4938949B2 (en)
AR (1) AR026038A1 (en)
AT (1) ATE309792T1 (en)
AU (1) AU7660900A (en)
DE (2) DE19949202A1 (en)
ES (1) ES2253257T3 (en)
WO (1) WO2001026637A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
AU2002308612B2 (en) 2001-05-01 2008-04-10 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2453013C (en) 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US7888546B2 (en) 2003-07-03 2011-02-15 Corium International, Inc. Wound dressing, ingredient delivery device and IV hold-down, and method relating to same
KR20070007299A (en) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. Rapidly dissolving film for delivery of an active agent
RU2393877C2 (en) 2004-08-05 2010-07-10 Кориум Интернэшнл, Инк. Adhesive composition
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
WO2011076401A1 (en) 2009-12-23 2011-06-30 Holger Schankin Substantially water-free pharmaceutical compositions containing acetylsalicylic acid
US20220265589A1 (en) * 2021-02-23 2022-08-25 Nanomed Skincare, Inc. Method of administering a dual therapeutic and cosmetic agent

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
ES2062093T3 (en) * 1988-08-02 1994-12-16 Ciba Geigy Ag PLASTER OF SEVERAL LAYERS.
JP2651616B2 (en) * 1989-02-03 1997-09-10 リンテック株式会社 Transdermal formulation
JPH0525045A (en) * 1991-07-18 1993-02-02 Tanabe Seiyaku Co Ltd Agent for transcutaneous absorption
KR960700041A (en) * 1993-01-21 1996-01-19 오노다 마사요시 Novel percutaneously absorbable preparation
DE4332093C2 (en) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermal therapeutic system with the active ingredient acetylsalicylic acid and process for its preparation
DE4332094C2 (en) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Active substance plaster which can be produced without solvent and process for its preparation
JP3496169B2 (en) * 1994-10-17 2004-02-09 大協薬品工業株式会社 Plaster and production method thereof
JPH08291068A (en) * 1995-04-21 1996-11-05 Sekisui Chem Co Ltd Eperisone plaster for external use
JPH0977902A (en) * 1995-09-12 1997-03-25 Shinko Refine Kk Undiluted volume reducing solution composition for polystyrene foam
DE19701059C2 (en) * 1997-01-15 2000-12-21 Lohmann Therapie Syst Lts Transdermal therapeutic system with absorption enhancement containing acetylsalicylic acid
JPH10279727A (en) * 1997-04-08 1998-10-20 Shinko Refine Kk Separation of volume-reducing solution from volumereduced polystyrene foam
JPH11222443A (en) * 1997-11-11 1999-08-17 Saitama Daiichi Seiyaku Kk Percutaneous absorption-promoting composition and percutaneous absorption preparation
JPH11209797A (en) * 1998-01-27 1999-08-03 Shogo Omae Cleaning agent

Also Published As

Publication number Publication date
WO2001026637A2 (en) 2001-04-19
JP2003511408A (en) 2003-03-25
EP1220661B1 (en) 2005-11-16
ATE309792T1 (en) 2005-12-15
EP1220661A2 (en) 2002-07-10
ES2253257T3 (en) 2006-06-01
DE50011653D1 (en) 2005-12-22
WO2001026637A3 (en) 2001-12-13
DE19949202A1 (en) 2001-05-03
JP4938949B2 (en) 2012-05-23
AR026038A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
AU6271401A (en) Drug administering system and administering method
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
IL131259A0 (en) Topical drug preparations
EP1216980A4 (en) Carboxylic acid derivatives and drugs containing the same
AU1585601A (en) Transdermal administration of huperzine
AU1764101A (en) Standard and track shelving system
IL138509A0 (en) Topical transdermal anesthetic formulation
AU7619900A (en) System for web-based payroll and benefits administration
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
AU2938100A (en) Transdermal drug delivery system and method
AU2002210463A1 (en) Transdermal therapeutic system
AU3539297A (en) Transdermal therapeutic systems
IL131229A (en) Compounds having enzymatic conversion inhibition for therapeutic intervention in preventing diabetic complications, pharmaceutical preparations and uses thereof
AU7660900A (en) Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
AU7662400A (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
IL149812A0 (en) Transdermal therapeutic systems having improved stability and their production
AU1164601A (en) Therapeutic use and formulation
HUP0200189A3 (en) Transdermal therapeutic system with nicotine
HUP0001739A3 (en) Solvent system for enhanced penetration of pharmaceutical compounds for topical use and the use of the buffer solvent system
AU7454698A (en) Improvement in medicament administration system
HUP0001486A3 (en) Pharmaceutical composition for topical use cantaining nimesulide gel systems and process for preparation thereof
HUP0002719A3 (en) Controlled release pharmaceutical preparation with ace inhibitor as active agent
AU3176695A (en) Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase